- Home
- IBEX vs AVIR Comparison
IBEX vs AVIR Comparison
Compare IBEX & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBEX
- AVIR
- Stock Information
- Founded
- IBEX 2017
- AVIR 2012
- Country
- IBEX United States
- AVIR United States
- Employees
- IBEX N/A
- AVIR N/A
- Industry
- IBEX EDP Services
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- IBEX Technology
- AVIR Health Care
- Exchange
- IBEX Nasdaq
- AVIR Nasdaq
- Market Cap
- IBEX 307.4M
- AVIR 273.7M
- IPO Year
- IBEX 2020
- AVIR 2020
- Fundamental
- Price
- IBEX $30.55
- AVIR $2.72
- Analyst Decision
- IBEX Buy
- AVIR Hold
- Analyst Count
- IBEX 2
- AVIR 1
- Target Price
- IBEX $25.00
- AVIR $6.00
- AVG Volume (30 Days)
- IBEX 173.9K
- AVIR 498.4K
- Earning Date
- IBEX 05-08-2025
- AVIR 05-20-2025
- Dividend Yield
- IBEX N/A
- AVIR N/A
- EPS Growth
- IBEX 48.53
- AVIR N/A
- EPS
- IBEX 2.25
- AVIR N/A
- Revenue
- IBEX $535,666,000.00
- AVIR N/A
- Revenue This Year
- IBEX $6.47
- AVIR N/A
- Revenue Next Year
- IBEX $4.29
- AVIR N/A
- P/E Ratio
- IBEX $13.56
- AVIR N/A
- Revenue Growth
- IBEX 5.35
- AVIR N/A
- 52 Week Low
- IBEX $13.61
- AVIR $2.60
- 52 Week High
- IBEX $27.83
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- IBEX 80.92
- AVIR 39.17
- Support Level
- IBEX $24.53
- AVIR $2.66
- Resistance Level
- IBEX $26.16
- AVIR $3.08
- Average True Range (ATR)
- IBEX 1.14
- AVIR 0.13
- MACD
- IBEX 0.50
- AVIR -0.02
- Stochastic Oscillator
- IBEX 83.37
- AVIR 14.29
About IBEX IBEX Limited
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).